Cancer codes (ICD-7; ICD-10) | Cancer cases/no. at risk | Person-years; annual incidence of cancer diagnosis per 100 (95% CI) | Hazard ratios (95% confidence intervals) | E-value | |
---|---|---|---|---|---|
Crude | Adjusted | ||||
All sites – first primary C (140–207; C00–96, D45–47) | |||||
Reference | 358,701/5451951 | 70,185,262; 0.507 (0.506–0.509) | 1.0 | 1.0 | 1.0 |
PCT (total) | 80/589 | 8368; 0.956 (0.768–1.190) | 1.1 (0.9–1.4) | 1.1 (0.9–1.3) | 1.4 |
Familial PCT | 25/245 | 3728; 0.671 (0.453–0.992) | 0.9 (0.6–1.4) | 0.9 (0.6–1.3) | 1.0 |
Sporadic PCT | 34/243 | 3547; 0.959 (0.685–1.342) | 1.1 (0.8–1.5) | 1.0 (0.7–1.4) | 1.1 |
Unclassified PCT | 21/101 | 1094; 1.920 (1.252–2.945) | 1.8 (1.1–2.7) | 1.6 (1.0–2.5) | 2.6 |
All sites – second primary C (140–207; C00–96, D45–47) | |||||
Reference | 57,505/5451951 | 71,305,121; 0.081 (0.080–0.081) | 1.0 | 1.0 | 1.0 |
PCT (total) | 26/589 | 8424; 0.309 (0.210–0.453) | 2.4 (1.6–3.5) | 2.2 (1.6–3.3) | 3.8 |
Familial PCT | 6/245 | 3749; 0.160 (0.72–0.356) | 1.5 (0.7–3.3) | 1.4 (0.6–3.1) | 2.2 |
Sporadic PCT | 14/243 | 3557; 0.394 (0.233–0.665) | 2.9 (1.7–4.9) | 2.8 (1.7–4.7) | 5.0 |
Unclassified PCT | 6/101 | 1119; 0.536 (0.241–1.194) | 2.8 (1.2–6.1) | 2.5 (1.1–5.6) | 4.4 |
Colon/rectum (153–154; C18-C21) | |||||
Reference | 46,077/5451951 | 71,375,873; 0.503 (0.501–0.504) | 1.0 | 1.0 | 1.0 |
PCT | 11/578 | 8564; 0.936 (0.752–1.165) | 1.2 (1.0–1.5) | 1.1 (0.9–1.4) | 1.4 |
Hepatocellular carcinoma (155.0; C22.0) | |||||
Reference | 1543/5451951 | 71,538,150; 0.002 (0.002–0.002) | 1.0 | 1.0 | 1.0 |
PCT (total) | 6/589 | 8567; 0.070 (0.031–0.156) | 19.9 (8.9–44.3) | 19.7 (8.8–44.0) | 38.9 |
Gallbladder and biliary tract (156; C23-C24) | |||||
Reference | 1628/5451951 | 71,537,477; 0.003 (0.003–0.003) | 1.0 | 1.0 | 1.0 |
PCT | 3/589 | 8576; 0.035 (0.011–0.108) | 7.2 (2.3–22.5) | 6.8 (2.2–21.0) | 13.0 |
Pancreas (157, C25) | |||||
Reference | 9830/5451951 | 71,375,873; 0.014 (0.014–0.014) | 1.0 | 1.0 | 1.0 |
PCT | 3/589 | 8546; 0.035 (0.011–0.109) | 1.6 (0.5–4.9) | 1.5 (0.5–4.6) | 2.4 |
Lung (162, C33–34) | |||||
Reference | 34,920/5451951 | 71,498,290; 0.049 (0.048–0.049) | 1.0 | 1.0 | 1.0 |
PCT | 13/589 | 8571; 0.152 (0.088–0.261) | 2.9 (1.7–5.0) | 1.6 (0.9–2.8) | 2.6 |
Non-melanoma skin (191, C44) | |||||
Reference | 16,048/5452,951 | 66,463,540; 0.024 (0.024–0.0024) | 1.0 | 1.0 | 1.0 |
PCT | 4/589 | 8533; 0.047 (0.018–0.125) | 1.9 (0.7–5.1) | 1.1 (0.4–3.5) | 1.4 |
Breast (170; C50) | |||||
Reference | 39,581/2713314 | 35,414,769; 0.112 (0.111–0.113) | 1.0 | 1.0 | 1.0 |
PCT | 5/299 | 4337; 0115 (0.048–0.277) | 0.6 (0.3–1.5) | 0.6 (0.3–1.7) | 1.0 |
Prostate (177; C61) | |||||
Reference | 56,652/2738637 | 35,644,567; 0.158 (0.157–0.159) | 1.0 | 1.0 | 1.0 |
PCT | 14/290 | 4170; 0.336 (0.199–0.567) | 1.2 (0.7–2.0) | 1.1 (0.6–1.8) | 1.4 |
Leukaemia (207; C91–95, D45–47) | |||||
Reference | 16,349/5451951 | 72,014,044; 0.023 (0.022–0.023) | 1.0 | 1.0 | 1.0 |
PCT | 4/589 | 8560; 0.023 (0.018–0.125) | 1.4 (0.5–3.7) | 1.3 (0.5–3.5) | 1.1 |